Pacific Biosciences of California Inc (NASDAQ: PACB) Now Carries A 12-Month Price Target Of $4.
Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares stood at 12.97 million during the last session, with the company’s beta value hitting 1.85. At the